Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy.

Bunschoten C, Jacobs BC, Van den Bergh PYK, Cornblath DR, van Doorn PA.

Lancet Neurol. 2019 May 7. pii: S1474-4422(19)30144-9. doi: 10.1016/S1474-4422(19)30144-9. [Epub ahead of print] Review.

PMID:
31076244
2.

Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis.

Broers MC, Bunschoten C, Nieboer D, Lingsma HF, Jacobs BC.

Neuroepidemiology. 2019;52(3-4):161-172. doi: 10.1159/000494291. Epub 2019 Jan 22.

3.

International chronic inflammatory demyelinating polyneuropathy outcome study (ICOS): Protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome.

Bunschoten C, Eftimov F, van der Pol WL, Jacobs BC; ICOS Consortium.

J Peripher Nerv Syst. 2019 Mar;24(1):34-38. doi: 10.1111/jns.12296. Epub 2019 Jan 22.

PMID:
30570196
4.

231st ENMC International Workshop:: International Standard for CIDP Registry and Biobank, Naarden, The Netherlands, 12-14 May 2017.

Eftimov F, Bunschoten C, Rajabally Y, Querol L; participants of the 231st ENMC workshop.

Neuromuscul Disord. 2018 Feb;28(2):178-184. doi: 10.1016/j.nmd.2017.10.009. Epub 2017 Dec 5. No abstract available.

5.

Mortality in Guillain-Barre syndrome.

van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC.

Neurology. 2013 Apr 30;80(18):1650-4. doi: 10.1212/WNL.0b013e3182904fcc. Epub 2013 Apr 10.

PMID:
23576619

Supplemental Content

Loading ...
Support Center